Evidence map›Paper›PMID 40080866›Full record

ArticleInternational journal of surgical pathology2025

Adenomatoid Tumor of the Liver with Prominent Admixed Cavernous Hemangioma-Like Vessels: An Exceptional Occurrence.

Ruoji Zhou, Hanlin L Wang

Abstract readCase Reports
In one paragraph

Article in International journal of surgical pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ruoji ZhouDepartment of Pathology and Laboratory Medicine, University of California at Los Angeles, Los Angeles, CA, USA.ORCID 0000-0001-7474-7156
Hanlin L WangDepartment of Pathology and Laboratory Medicine, University of California at Los Angeles, Los Angeles, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adenomatoid tumors are benign neoplasms of mesothelial phenotype, commonly found in the genital tracts. Hepatic adenomatoid tumors are extremely uncommon and can present diagnostic challenges, particularly when mixed with other histologic elements. Here we report an adenomatoid tumor with prominent admixed cavernous hemangioma-like vessels in the liver of a 58-year-old woman. Grossly, the tumor appeared as a pedunculated lesion on the hepatic surface with cystic spaces filled with blood. Microscopic examination revealed numerous blood vessels of varying sizes intermingled with anastomosing tubular structures lined by cuboidal epithelioid cells that were immunohistochemically positive for mesothelial markers. Areas of typical cavernous hemangioma were also present within the same lesion. To our knowledge, this tumor represents the first documented instance of an adenomatoid tumor with prominent admixed cavernous hemangioma-like vessels in the liver. Our case report summarizes previously reported hepatic adenomatoid tumors and highlights their clinical, histopathologic, and immunohistochemical features. Given the various morphologic presentations, adenomatoid tumors can mimic other neoplasms. Their benign nature and excellent prognosis with complete surgical resection make accurate diagnosis crucial. Increased understanding and awareness of this uncommon tumor, combined with morphologic analysis and immunohistochemical studies, can help overcome diagnostic challenges to ensure accurate diagnosis and appropriate clinical management.

Indexed as

Adenomatoid TumorHemangioma, CavernousLiverLiver NeoplasmsBiomarkers, TumorDiagnosis, DifferentialFemaleHumansImmunohistochemistryMiddle AgedBiomarkers, Tumoradenomatoid tumorhemangiomaimmunohistochemistryliver

Identifiers

PMID40080866
PMCPMC12276407

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.